![Nandan Padukone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nandan Padukone worked at ImmunoMolecular Therapeutics, Inc. from 2019 to 2023 as Chief Executive Officer.
Prior experience includes a role as Senior Vice President-Innovations at Joslin Diabetes Center, Inc.
Anciens postes connus de Nandan Padukone
| Sociétés | Poste | Fin |
|---|---|---|
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Directeur Général | 01/01/2023 |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for diabetes | Corporate Officer/Principal | 02/01/1990 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for diabetes | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
